🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
Background: The number of patients with esophageal cancer keeps rising. Fo...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2017-10-31
Trial ID
NCT03223662
Treatments Being Tested
This is a phase II/III randomized controlled trial to evaluate efficacy of ...
Status
Unknown
Location
N.N. Blokhin Cancer Research Center
Start Date
2019-09-01
Trial ID
NCT04055038
Treatments Being Tested
Patients enrolled on this study will have been diagnosed with non-small cel...
Status
Completed
Location
University of North Carolina Lineberger Comprehensive Cancer Center
Start Date
2003-11
Trial ID
NCT00280787
Treatments Being Tested
Evaluate the efficacy and safety of neoadjuvant chemotherapy (NAC) with alb...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2022-03-14
Trial ID
NCT05367206
Treatments Being Tested
This phase II trial tests whether panitumumab and pembrolizumab in combinat...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2022-03-11
Trial ID
NCT05177796
Treatments Being Tested
To compare outcomes between the CRS group and the control group in patients...
Status
Recruiting
Location
National Cancer Center, Korea
Start Date
2025-09-10
Trial ID
NCT07171528
Treatments Being Tested
This is a Phase I, single-arm, open-label, prospective, non-randomized, sin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-31
Trial ID
NCT07724106
Treatments Being Tested
The primary objective of the study is to determine the maximum tolerated do...
Status
Completed
Location
Alabama Oncology
Start Date
2013-03-29
Trial ID
NCT01803282